19:47 , Dec 8, 2017 |  BC Extra  |  Financial News

Tasly unit invests $50M in Chinese diabetes play Genova

Genova Biotech Co. Ltd. (Changzhou, China) received a $50 million investment from an undisclosed subsidiary of Tasly Holdings Group Co. Ltd. (Shanghai:600535). According to Genova financial advisor China Renaissance, the investment is part of Genova’s...
08:00 , Dec 14, 2015 |  BC Week In Review  |  Financial News

Aslan completes venture financing

Aslan Pharmaceuticals Pte. Ltd. , Singapore   Business: Cancer, Inflammation, Pulmonary   Date completed: 2015-12-07   Type: Venture financing   Raised: $34 million   Investors: Temasek Holdings Pte. Ltd.; Tianda Pharmaceuticals Ltd.; Haitong International; Morningside...
02:33 , Dec 8, 2015 |  BC Extra  |  Financial News

Aslan raises $34M in series C round

Aslan Pharmaceuticals Pte. Ltd. (Singapore) raised $34 million in a series C round led by the Accuron Technologies Ltd. subsidiary of Temasek Holdings. New investors Tianda Pharmaceuticals Ltd. (Hong Kong, China) and Haitong International also...
07:00 , Apr 14, 2014 |  BC Week In Review  |  Financial News

BVCF financial update

BVCF closed its third dollar-denominated fund, BVCF III, with about $200 million. The firm (formerly BioVeda China) plans to invest about $5-$25 million in about 10 life sciences and healthcare companies in China. BVCF ,...
00:22 , Apr 9, 2014 |  BC Extra  |  Financial News

BVCF closes $200 million fund

BVCF Management closed its third dollar-denominated fund, BVCF III, with about $200 million. The firm (formerly BioVeda China) plans to invest about $5-$25 million in about 10 life sciences and healthcare companies in China (see...
07:00 , Oct 28, 2013 |  BioCentury  |  Finance

Asian leverage

Asian leverage Aslan Pharmaceuticals Pte. Ltd. tapped into VCs with operational expertise in Asia for its latest round and plans to use the cash to build out its portfolio of in-licensed products. Aslan raised $22...
07:00 , Oct 14, 2013 |  BC Week In Review  |  Financial News

Aslan completes venture financing

Aslan Pharmaceuticals Pte. Ltd. , Singapore   Business: Cancer, Inflammation, Pulmonary   Date completed: 10/10/13   Type: Venture financing   Raised: $22 million   Investors: Cenova Ventures; Morningside Group; XinChen Ventures; BioVeda; Sagamore Bioventures  ...
23:46 , Oct 10, 2013 |  BC Extra  |  Financial News

Aslan raises $22 million in series B

Aslan Pharmaceuticals Pte. Ltd. (Singapore) raised $22 million in a series B round led by new investor Cenova Ventures. New investors Morningside Group; and XinChen Ventures also participated along with existing investors BioVeda Capital; and...
07:00 , Mar 25, 2013 |  BC Week In Review  |  Financial News

Clearbridge BioMedics completes venture financing

Clearbridge BioMedics , Singapore   Business: Diagnostic   Date completed: 3/13/13   Type: Venture financing   Raised: S$9 million ($7.2 million)   Investors: Vertex Venture Holdings; Spring Seeds Capital; Clearbridge BSA; BioVeda; individual investor  ...
07:00 , Oct 3, 2011 |  BioCentury  |  Emerging Company Profile

Aslan: A bridge to Phase III

Aslan Pharmaceuticals Pte. Ltd. is providing a bridge for partners that have too many early stage assets. The company's business model is to pick up molecules to develop through Phase II proof-of-concept trials. Aslan will...